Search

Aditi Dutt

Examiner (ID: 15807, Phone: (571)272-9037 , Office: P/1649 )

Most Active Art Unit
1649
Art Unit(s)
1649, 1675
Total Applications
622
Issued Applications
221
Pending Applications
78
Abandoned Applications
328

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19550955 [patent_doc_number] => 12134651 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-11-05 [patent_title] => Anti-Ryk antibodies and methods of using the same [patent_app_type] => utility [patent_app_number] => 17/127913 [patent_app_country] => US [patent_app_date] => 2020-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 98 [patent_no_of_words] => 32115 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17127913 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/127913
Anti-Ryk antibodies and methods of using the same Dec 17, 2020 Issued
Array ( [id] => 16915879 [patent_doc_number] => 20210188971 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-24 [patent_title] => MONOCLONAL ANTIBODY FUSIONS [patent_app_type] => utility [patent_app_number] => 17/127810 [patent_app_country] => US [patent_app_date] => 2020-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24159 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17127810 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/127810
MONOCLONAL ANTIBODY FUSIONS Dec 17, 2020 Pending
Array ( [id] => 16806134 [patent_doc_number] => 20210128687 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-06 [patent_title] => METHOD OF EFFECTING NEUROPROTECTION USING SOLUBLE NEUREGULIN ISOFORMS [patent_app_type] => utility [patent_app_number] => 17/126351 [patent_app_country] => US [patent_app_date] => 2020-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11276 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17126351 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/126351
METHOD OF EFFECTING NEUROPROTECTION USING SOLUBLE NEUREGULIN ISOFORMS Dec 17, 2020 Abandoned
Array ( [id] => 17143010 [patent_doc_number] => 20210311023 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-07 [patent_title] => CHEMICAL COCKTAIL FOR INDUCING SENESCENCE IN HUMAN NEURONS TO PROMOTE DISEASE MODELING AND DRUG DISCOVERY [patent_app_type] => utility [patent_app_number] => 17/117096 [patent_app_country] => US [patent_app_date] => 2020-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12147 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17117096 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/117096
CHEMICAL COCKTAIL FOR INDUCING SENESCENCE IN HUMAN NEURONS TO PROMOTE DISEASE MODELING AND DRUG DISCOVERY Dec 8, 2020 Pending
Array ( [id] => 16948115 [patent_doc_number] => 20210206806 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-08 [patent_title] => PEPTIDIC LINKER WITH REDUCED POST-TRANSLATIONAL MODIFICATION [patent_app_type] => utility [patent_app_number] => 17/111820 [patent_app_country] => US [patent_app_date] => 2020-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17132 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 165 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17111820 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/111820
PEPTIDIC LINKER WITH REDUCED POST-TRANSLATIONAL MODIFICATION Dec 3, 2020 Pending
Array ( [id] => 17445369 [patent_doc_number] => 20220065874 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-03 [patent_title] => METHODS FOR THE IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF NEUROLOGICAL DISORDERS AND DISEASES [patent_app_type] => utility [patent_app_number] => 17/013974 [patent_app_country] => US [patent_app_date] => 2020-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6803 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17013974 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/013974
METHODS FOR THE IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF NEUROLOGICAL DISORDERS AND DISEASES Sep 7, 2020 Abandoned
Array ( [id] => 19839068 [patent_doc_number] => 12251423 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-03-18 [patent_title] => Method of effecting neuroprotection using soluble neuregulin isoforms [patent_app_type] => utility [patent_app_number] => 17/012159 [patent_app_country] => US [patent_app_date] => 2020-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 11305 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17012159 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/012159
Method of effecting neuroprotection using soluble neuregulin isoforms Sep 3, 2020 Issued
Array ( [id] => 16398789 [patent_doc_number] => 20200339647 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-29 [patent_title] => INHIBITOR OF ASTROCYTE TNF ALPHA FOR USE IN THE TREATMENT OF NEUROLOGICAL DISEASES [patent_app_type] => utility [patent_app_number] => 16/928735 [patent_app_country] => US [patent_app_date] => 2020-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7206 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16928735 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/928735
INHIBITOR OF ASTROCYTE TNF ALPHA FOR USE IN THE TREATMENT OF NEUROLOGICAL DISEASES Jul 13, 2020 Abandoned
Array ( [id] => 18225496 [patent_doc_number] => 20230064490 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-02 [patent_title] => FLUORESCENT PROTEIN BIOSENSOR FOR DETECTION OF KINASE ACTIVITY [patent_app_type] => utility [patent_app_number] => 16/923927 [patent_app_country] => US [patent_app_date] => 2020-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14233 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16923927 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/923927
FLUORESCENT PROTEIN BIOSENSOR FOR DETECTION OF KINASE ACTIVITY Jul 7, 2020 Abandoned
Array ( [id] => 16791724 [patent_doc_number] => 20210121541 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-29 [patent_title] => CGRP Antagonists and Clostridial Derivatives for the Treatment of Neuropsychiatric and Neurological Disorders [patent_app_type] => utility [patent_app_number] => 16/921502 [patent_app_country] => US [patent_app_date] => 2020-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15216 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16921502 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/921502
CGRP Antagonists and Clostridial Derivatives for the Treatment of Neuropsychiatric and Neurological Disorders Jul 5, 2020 Abandoned
Array ( [id] => 16514150 [patent_doc_number] => 20200393408 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-17 [patent_title] => ALLERGY ANTIGEN AND EPITOPE THEREOF [patent_app_type] => utility [patent_app_number] => 16/899643 [patent_app_country] => US [patent_app_date] => 2020-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38555 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 1144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16899643 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/899643
ALLERGY ANTIGEN AND EPITOPE THEREOF Jun 11, 2020 Abandoned
Array ( [id] => 17750853 [patent_doc_number] => 20220229058 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-21 [patent_title] => NOROVIRUS-BINDING PEPTIDE [patent_app_type] => utility [patent_app_number] => 17/613310 [patent_app_country] => US [patent_app_date] => 2020-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10111 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17613310 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/613310
Norovirus-binding peptide May 27, 2020 Issued
Array ( [id] => 16726465 [patent_doc_number] => 20210093612 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-01 [patent_title] => SYSTEMS AND METHODS TO TREAT PAIN LOCALLY [patent_app_type] => utility [patent_app_number] => 16/874984 [patent_app_country] => US [patent_app_date] => 2020-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7574 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16874984 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/874984
SYSTEMS AND METHODS TO TREAT PAIN LOCALLY May 14, 2020 Abandoned
Array ( [id] => 16466828 [patent_doc_number] => 20200368365 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-26 [patent_title] => COMPOUNDS AND COMPOSITIONS FOR TARGETING BRAIN INJURIES AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/859893 [patent_app_country] => US [patent_app_date] => 2020-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35080 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16859893 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/859893
Compounds and compositions for targeting brain injuries and methods of use thereof Apr 26, 2020 Issued
Array ( [id] => 18013339 [patent_doc_number] => 11505621 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-11-22 [patent_title] => H1.0K180me2 antibodies, methods of making and uses thereof [patent_app_type] => utility [patent_app_number] => 16/857091 [patent_app_country] => US [patent_app_date] => 2020-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 33 [patent_no_of_words] => 23350 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16857091 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/857091
H1.0K180me2 antibodies, methods of making and uses thereof Apr 22, 2020 Issued
Array ( [id] => 16238655 [patent_doc_number] => 20200255889 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-13 [patent_title] => SEROLOGICAL ASSAY FOR DETECTION OF EXPOSURE TO AND INFECTION BY TICK-BORNE PATHOGENS [patent_app_type] => utility [patent_app_number] => 16/828483 [patent_app_country] => US [patent_app_date] => 2020-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20571 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16828483 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/828483
SEROLOGICAL ASSAY FOR DETECTION OF EXPOSURE TO AND INFECTION BY TICK-BORNE PATHOGENS Mar 23, 2020 Pending
Array ( [id] => 16175500 [patent_doc_number] => 20200222468 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-16 [patent_title] => IN VITRO MODEL FOR NEURONAL DEATH [patent_app_type] => utility [patent_app_number] => 16/826981 [patent_app_country] => US [patent_app_date] => 2020-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7613 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16826981 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/826981
In vitro model for neuronal death Mar 22, 2020 Issued
Array ( [id] => 17611864 [patent_doc_number] => 20220154143 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-19 [patent_title] => Culture Method for Head and Neck Organoids [patent_app_type] => utility [patent_app_number] => 17/437477 [patent_app_country] => US [patent_app_date] => 2020-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31924 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17437477 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/437477
Culture Method for Head and Neck Organoids Mar 15, 2020 Pending
Array ( [id] => 15927687 [patent_doc_number] => 20200155477 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-21 [patent_title] => CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS [patent_app_type] => utility [patent_app_number] => 16/782094 [patent_app_country] => US [patent_app_date] => 2020-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22285 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16782094 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/782094
Cladribine regimen for treating multiple sclerosis Feb 4, 2020 Issued
16/727131 MODULATING VENULENESS OF ENDOTHELIAL CELLS Dec 25, 2019 Abandoned
Menu